BannerInterno

Scientific Program



    • Not included in the Congress registration free. For attending the Workshop, you can register here.
      08:30-13:10

      PRECONGRESS WORKSHOP: Male infertility under a 360º view

      • Session I:
        Male infertility epidemiology and the best medical practice based on evidence              
        Chairs: Nicolás Garrido (Spain) / Craig Niederberger (USA)
      • 08:30-08:40
        Introduction
        Nicolás Garrido (Spain)
      • 08:40-09:00
        Male reproductive health status: A global initiative towards solving male infertility
        Chris Barratt (Scotland)
      • 09:00-09:10
        Q&A
      • 09:10-09:30
        Male fertility as a predictor of future health problems
        Mike Eisenberg (USA)
      • 09:30-09:40
        Q&A
      • 09:40-10:00
        Varicocele, what have we learned in this century?
        Rossella Cannarella (Italy)
      • 10:00-10:10
        Q&A
      • 10:10-10:30
        How 4K-3D microscope can improve our results in male infertility surgery?
        Juan Manuel Corral (Spain)
      • 10:30-10:40
        Q&A
      • 10:40-11:10 Coffee break

      • Session II:
        The laboratory tests helping the characterization of male infertility              
        Chairs: Jim Hotaling (USA) / Marga Esbert (Spain)
      • 11:10-11:30
        The changes introduced by the WHO 2021 Manual and their impact and changes
        Chris Barratt (Scotland)
      • 11:30-11:40
        Q&A
      • 11:40-12:00
        Subtle genetic causes of male infertility beyond chromosomes
        Csilla Krausz (Italy)
      • 12:00-12:10
        Q&A
      • 12:10-12:30
        Exosomes in male fertility. How close we are from a clinical application
        Alberto Pacheco (Spain)
      • 12:30-12:40
        Q&A
      • 12:40-13:00
        How the metrics and outcomes for male infertility research should be analysed
        Craig Niederberger (USA)
      • 13:00-13:10
        Q&A
    • Included in the Congress registration fee
      PREIMPLANTATION GENETIC TESTING (PGT) SYMPOSIUM
      1ST SESSION: CLINIC SCIENCE
      09:30-10:00

      Historical Overview of PGT
      Dagan Wells (United Kingdom)

      10:00-10:30 Evolving indication and technologies for PGT-M and SR
      Dhruti Babariya (United Kingdom)
      10:30-11:00 The benefit of genotyping in PGT-A: clinical and research perspectie
      Antonio Capalbo (Italy)
      11:00-11:30 Evidence based clinical reporting and genetic counseling by PGT-A seq.
      Emily Mounts (USA)
      11:30-11:45 Coffee Break
      2ND SESSION: PRACTICAL EMBRYOLOGY
      11:45-12:10 Embryology laboratories good practice–tips and tricks
      Christian Ottolini (Italy)
      12:10-12:35 Practical experience with TE biopsy in a busy PGT lab.
      Fernando Bronet (Spain)
      12:35-13:00 Practical experience with TE biopsy in a startup PGT lab
      Isabel González-Mesien (Spain)
  •  13:45-14:00 OPENING CEREMONY
    14:00-16:00

    OVARIAN STIMULATION
    Chairs:
    Tom Molinaro (USA) / Laura Melado (Spain)

    • 14:00-14:30
      Individualized approach vs “coffee for all”
      Ernesto Bosch (Spain)
    • 14:30-15:00
      Dual Stim
      Filipo Ubaldi (Italy)
    • 15:00-15.30
      Luteal phase / random start as the ideal start
      Michel De Vos (Belgium)
    • 15:30-16:00   
      Progesterone primed ovarian stimulation

      Baris Ata (Turkey)
    16:00-16:30 Coffee break
    16:30-17:45

    PREMATURE OVARIAN INSUFFICIENCY: WHAT IS NEW?
    Chairs:
    Cristina Pozzobon (Italy) / Sérgio Soares (Portugal)

    • 16:30-16:55
      Genetics of ovarian aging and dysfunction
      Joop Laven (The Netherlands)
    • 16:55-17:20
      How to manage the POI patient
      Anne Gompel (France) 
    • 17:20-17:45
      Reactivation of dormant ovarian follicles: An update on IVA, ASCOT and PRP
      Nuria Pellicer (Spain)
    17:45-18:45 Industry-sponsored Symposium I
    18:45-19:45

    DEBATE 1: THE WINDOW OF IMPLANTATION: DOES IT EXIST?
    Chair:
    José Serna (Spain)

    • What classical clinical data suggest
      Richard Paulson (USA)
    • What have we learned from modern transcriptomics
      Patricia Díaz-Gimeno (Spain)
    19:45-20:30 Welcome reception
    • 08:30-10:30

      THE ENDOMETRIUM
      Chairs: Cesar Díaz (Spain) / Renato Fanchin (France)

      • 08:30-09:00
        Endometrial immune profile: Changes in an injured endometrium       
        Diana Alecsandru (Spain)
      • 09:00-09:30
        Decidualization or endometrial receptivity?
        Nick Macklon (United Kingdom)
      • 09:30-10:00 
        Clinical option for the management of poor endometrium
        Marcos Ferrando (Spain)
      • 10:00-10:30
        Impact of dysbiosis/chronic endometritis in implantation
        Henriette Svarre Nielsen (Denmark)
      10:30-11:00 Coffee break
      11:00-12:30

      ADENOMYOSIS
      Chairs:
      Ana Isabel Salazar (Spain) / Geeta Nargund (UK)

      • 11:00-11:30
        Pathophysiology
        Serdar Bulun (USA)
      • 11:30-12:00
        Ultrasound assessment
        Caterina Exacoustos (Italy)
      • 12:00-12:30
        Influence on ART outcomes
        Mauro Cozzolino (Italy)
      12:30-13:30

      DEBATE 2: IS DIMINISHED OVARIAN RESERVE A MARKER OF INCREASED ANEUPLOIDY?
      Chair:
      Antonio Pellicer (Italy)

      • YES
        Marcelle Cedars (USA)
      • NO
        Scott Morin (USA)
      13:30-14:30 Lunch
      14:30-16:00

      NEW METHODS OF EMBRYO SELECTION
      Chairs:
      Javier Domingo (Spain) / Elkin Muñoz (Spain)

      • 14:30-15:00
        Fluorescence lifetime imaging: Following the energy
        Denny Sakkas (USA)
      • 15:00-15:30
        Mitochondria and embryo viability: What is new?
        Emre Seli (USA)
      • 15:30-16:00
        Advances in the study of culture media metabolomics
        Santiago Munne (Spain)
      16:00-16:30 Coffee break
      16:30-18:00

      AI IN ART
      Chairs:
      Clara Colomé (Spain) / Rina Agrawal (United Kingdom)

      • 16:30-17:00
        AI performance for embryo selection
        Marcos Meseguer (Spain)
      • 17:00-17:30
        Time to replace biopsy based PGT-A with non-invasive AI based decision tools
        Daniella Gilboa (Israel)
      • 17:30-18:00
        How AI may help clinical decision making in ART
        Antonio Urda (Spain)
      18:00-19:00

      DEBATE 3: ARE WE DISCARDING NORMAL EMBRYOS USING PGT-A?
      Chair:
      Dagan Wells (UK)

      • YES
        Norbert Gleicher (USA)
      • NO
        Antonio Capalbo (Italy)
    • 08:30-10:35

      PARALLEL SESSION – EMBRYOLOGY I
      Chairs:
      Fernando Bronet (Spain) / Alexander Quaas (Switzerland)

      • 08:30-08:55 Understanding the origins of embryo aneuploidy    
        Antonio Capalbo (Italy)
      • 08:55-09:20 Transcriptomics of androgenotes and parthenothes in early stages of development
        Francisco Domínguez (Spain)
      • 09:20-09:45 The transcriptional signature of mosaic embryos
        Angel Martin (Spain)
      • 09:45-10:10 Increasing the chances of having  good embryos  to select. Embryo culture conditions
        Jason Swain (USA)
      • 10:10-10:35 Increasing the chances of having  good embryos  to select. The IVF laboratory automation
        Joseph Conaghan (USA)
      10:35-11:00 Coffee break
      11:00-13:30

      PARALLEL SESSION - EMBRYOLOGY II
      Chairs:
      Maria José De Los Santos (Spain) / Nicolás Prados (Spain)

      • 11:00-11:30 Non genetic markers of embryo quality: Are them reliable enough?
        Laura Rienzi (Italy)
      • 11:30-12:00 Non invasive PGT: How close are we to the finish
        Dagan Wells (United Kingdom)
      • 12:00-12:30 The deep learning on embryo selection
        Marcos Meseguer (Spain)
      • 12:30-13:00 Optimizing patient care through evidence-based embryo diagnostics
        Chaim Jalas (USA)
      • 13:00-13:30 PGT Plus  (double sequency methodology for embryo selection)
        Svetlana Madjunkova (Canada)
    • 13:30-14:30 Industry-sponsored Symposium II
      A packed lunch will be offered to all attendees
  • 08:00-09:45

    LUTEAL PHASE SUPPORT
    Chairs:
    Antonio Requena (Spain) / Kazem Nouri (Austria)

    • 08:00-08:25 Differences in luteal support in spontaneous vs stim cycle  
      Peter Humaidan (Denmark)
    • 08:25-08:55 Luteal phase support in the natural/stim/HRT cycle
      Elena Labarta (Spain)
    • 08:55-09:20 Role of Corpus luteum in prevention of preeclampsia
      Frauke von Versen-Höynck (Germany)
    • 09:20-09:45 Differences in obstetrics / maternal outcome according to cycle preparation
      Cristina Bergh (Sweden)
    09:45-10.15 Coffee break
    10:15-11:30

    RECURRENT IMPLANTATION FAILURE
    Chairs
    : Alfonso Bermejo (Spain) / Marcos Ferrando (Spain)

    • 10:15-10:40 The clinician perspective
      Tom Molinaro (USA)
    • 10:40-11:05 The IVF laboratory point of view
      Maria José de los Santos (Spain)
    • 11:05-11:30 The psychologist approach
      Jacky Boivin (United Kingdom)
    11:30-13:05

    FUTURE PERSPECTIVES
    Chairs: Emre Seli (USA) / Ernesto Bosch (Spain)

    • 11:30-11:55 Mechanisms governing human ovarian aging
      Juan Carlos Izpisua Belmonte (USA)
    • 11:55-12:20 Ex utero synthetic embryogenesis: from naïve stem cells to embryos
      Jacob Hanna (Israel)
    • 12:20-12:45 Strategies to repair damaged oocytes
      Sonia Herraiz (Spain)
    • 12:45-13:05 Creating spermatozoa
      Jim Hotaling (USA)
    13:05-13:30 CLOSING

CEST time

Important Dates


  • ABSTRACTS
    Abstract Submission form will end on
    March, 15th 2023
  • REGISTRATIONS
    Early Bird Registration until 
    February 21st, 2023

renfe
The organization of the congress has agreed with RENFE (the national Railway Company) a 5% discount for the train tickets for national round trips for all participants. The discount will be available between April 18th – April 24th (both inclusive). In order to obtain the discount you need to be registered to the Congress.

To request it please just send an email to Esta dirección de correo electrónico está siendo protegida contra los robots de spam. Necesita tener JavaScript habilitado para poder verlo.